Delivery Order SPE2DB20D9214-SPE2DB24FD4SU
Award Date 3/22/24
Potential Completion Date 4/12/24
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $118,288.32, is for the delivery of Entyvio 300 mg vials. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that runs through December 31, 2025. The IDC allows the DLA to issue delivery orders for a comprehensive range of...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Entyvio 300 mg vials. The contract has a potential value of $29,572.08 and a completion date of February 16, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds a larger indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, to supply a wide range of pharmaceutical products to military...
- The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Entyvio 300 mg vials. The $98,573.60 firm-fixed-price contract has an ultimate completion date of April 23, 2024. This award is part of DMS Pharmaceutical Group's broader indefinite delivery contract with DLA, valued at up to $4,999,999 through 2025, to supply a wide range of pharmaceuticals to support military health facilities...
- The Defense Logistics Agency (DLA) awarded a $115,494.24 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Entyvio 300 mg vials. This order is being fulfilled under a larger indefinite delivery contract with DMS Pharmaceutical Group to provide a variety of pharmaceutical and medical products to support the operations of military treatment facilities worldwide. The contract does not have a set-aside designation and is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $34,500.76, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, that allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Entyvio 300 mg vials. The $98,573.60 contract has a completion date of February 15, 2024. DMS Pharmaceutical Group is an experienced pharmaceutical wholesaler that holds an indefinite delivery contract with the Defense Logistics Agency, enabling the agency to issue delivery orders for a wide range of medical supplies...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Entyvio 300 mg vials. The $226,837.92 award has a completion date of November 3, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles with DLA to supply pharmaceuticals and medical products in support of military...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Entyvio 300 mg vials. The order is valued at $96,245.20 and has a performance period through January 17, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with DLA Troop Support Medical to supply a variety of pharmaceutical and medical products in support of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $147,860.40 contract is for the delivery of Entyvio 300 mg vials, a biologic medication, to support the recurring pharmaceutical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to...
- The U.S. government's Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $24,643.40 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Entyvio 300 mg vials. This delivery order is part of a larger indefinite delivery contract (SPE2DB22D9143) with a ceiling value of up to $4,999,999 that enables DLA to issue orders for a wide range of pharmaceutical products to support military health facilities. DMS Pharmaceutical Group Inc....